IDH1 and glioma: IDH1 R132H mutant gliomas famously exhibit a glioma-associated CpG island methylator phenotype (or G-CIMP), which arises from the competitive inhibition of DNA-demethylating TET proteins by the oncometabolite 2-HG30.